I've heard a ceo fron a different company say 50,000 per patient to treat ards with their stem cell tech which seems high to me but that is what was stated. But anyway there is no shortage of money when it is a breakthrough life saving treatment. Partners, licensing agreements or a buyout for this type of business.
News 
Market Data 
Discover 
